Rationale: ASK1-interacting protein-1 (AIP1), a Ras GTPase-activating protein family member, is highly expressed in endothelial cells and vascular smooth musccells (VSMCs). The role of AIP1 in VSMCs and VSMC proliferative disease is not known.
JAK1 and JAK2, and subsequent tyrosine phosphorylation of IFN-␥R. Phosphorylation of IFN-␥R results in recruitment, JAK-mediated tyrosine phosphorylation, dimerization, and nuclear translocation of STAT1, which in turn induces expression of IFN-␥-responsive genes. 15, 16 IFN-␥ may also activate STAT3 in some cell types, including VSMCs, [17] [18] [19] [20] and STAT3 signaling is primarily involved in cellular growth and survival. [17] [18] [19] [20] In VSMCs, IFN-␥ also activates STAT-independent but PI3K-Akt-mTOR (phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin)-dependent proliferation. 21 Cellular mechanisms regulating these IFN-␥ pathways are less well understood. In the present study, we have identified AIP1 as an endogenous cellular inhibitor of IFN-␥-dependent arteriosclerosis. ASK1interacting protein 1 (AIP1, also known as DAB2-interacting protein [DAB2IP]), is a novel member of the Ras-GAP (Ras-GTPase-activating protein) protein family. In addition to the GAP domain, AIP1 also contains other structural domains, including a plekstrin homology (PH) and protein kinase C conserved domain (C2) in its N-terminal half and a period-like domain, a proline-rich region, a leucine zipper, phosphoserines for 14-3-3 binding, and an Akt-binding domain in its C-terminal half. [22] [23] [24] [25] [26] In ECs, AIP1 functions as an adaptor molecule that activates proapoptotic ASK1 while inhibiting prosurvival IB␣ kinase and PI3K. [22] [23] [24] [25] [26] [27] [28] [29] AIP1 is also highly expressed in VSMCs. 24, 27, 30 In the present study, we investigated the role of AIP1 in VSMC proliferation in vitro and intima formation in vivo.
Methods
An expanded Methods section, which includes data on the mouse graft transplantation model, graft analyses, aorta organ and cell culture, immunoprecipitation/immunoblotting, in vitro VSMC migration and proliferation assays, and statistical analyses, is available in the Online Data Supplement at http://circres.ahajournals.org.
Results

AIP1 Deletion Enhances IFN-␥-Dependent Neointima Formation in a Mouse Graft Arteriosclerosis Model
AIP1-knockout (KO) mice appear developmentally normal, with no obvious defects in blood vessel formation and maturation. 27 To determine the function of AIP1 in VSMC in pathological settings, we used mouse GA models characterized by VSMC proliferation and intimal expansion. In our allograft model, a segment of a male donor thoracic aorta is interposed into the abdominal aorta of a female recipient. The host then mounts a T cell-mediated alloimmune response against the male-specific minor histocompatibility antigen H-Y expressed by the graft, 31 in which T cell-produced IFN-␥ drives graft VSMC proliferation [1] [2] [3] [4] 32, 33 (Online Figure I) . Wild-type (WT) male-to-WT female transplantation induced GA, characterized by infiltration of leukocytes and neointima formation with accumulation of VSMCs ( Figure  1A ). AIP1-KO male donor grafts to WT female recipients generated significantly more neointima that contained more smooth muscle cell actin (SMA)-positive cells but similar numbers of leukocytes compared with the WT donor group ( Figure 1A , with quantification in Figure 1B ). Expression of signature genes for Th1 cells (IFN-␥, tumor necrosis factor-␣, and T-bet), and Treg (transforming growth factor-␤ and Foxp3) but not Th2 (interleukin-4) or Th17 (interleukin-17) was detected by quantitative real-time polymerase chain reaction, which suggests that Th1 and Treg are the major T cells involved in this mouse GA model. No significant differences between WT and AIP1-KO in gene expression of Th1 and Treg signature genes were detected (Online Figure I, D). However, induction of IFN-␥-induced genes (IP-10 and Mig) was higher in the grafts of AIP1-KO than in the WT donor group, as shown for both mRNA ( Figure 1C ) and protein ( Figures 1D and 1E ). These data suggest that AIP1 deletion does not alter the T subtypes in GA but instead affects the IFN-␥ responses of VSMCs to T cells. Of note, IFN-␥-induced chemokines such as IP-10 and Mig not only serve as IFN-␥ signature genes but also play active roles in GA progression. Specifically, IP-10 has been shown to be involved in VSMC migration and proliferation. 34, 35 To determine the role of IFN-␥ signaling in AIP1 deletionaugmented GA, we bred AIP1-KO into IFN-␥Rdeficient (IFN-␥R-KO) background mice to generate AIP1-KO/IFN-␥R-KO mice (double knockout [DKO]). Aortas from WT, IFN-␥R-KO, AIP1-KO, or DKO mice were transplanted into WT female recipients. Deletion of IFN-␥R in donor grafts caused reduced infiltration of leukocytes and neointima formation, with decreases of SMA ϩ cells compared with WT grafts (Online Figure . These results support a critical role for IFN-␥ signaling in GA progression in our mouse model, as previously observed in a humanized mouse xenograft transplantation model. 10, 11, 13, 14 
AIP1 Deletion Augments IFN-␥-Induced GA
Human IFN-␥ alone is sufficient to induce neointima formation in human artery xenografts. 13, 14 To directly determine the role of AIP1 in IFN-␥-mediated GA progression, we established an IFN-␥-mediated mouse syngeneic GA model. WT or AIP1-KO male aortas were transplanted into IFN-␥Rdeficient recipient mice, followed by intravenous injection of replication-deficient adenovirus encoding the mouse IFN-␥ transgene (Ad-IFN-␥) or the control LacZ gene (Ad-LacZ; Online Figure III, A for illustration and scheme of the protocol). Hepatic infection and liver transgene expression of Ad-LacZ were verified by X-gal staining in the Ad-LacZ group but not the Ad-IFN-␥ groups, as described previously. 14 Systemic expression of IFN-␥ in serum was detected at a level of 120 to 150 ng/mL on day 3 and retained up to 5
Non-Standard Abbreviations and Acronyms AIP1
ASK1-interacting protein-1
EC endothelial cells
GA graft arteriosclerosis
PH plekstrin homology weeks in the Ad-IFN-␥ but not the Ad-LacZ group (Online Figure III, B ). This extended duration of IFN-␥ expression in IFN-␥R-KO recipients was similar to that observed in SCID/ beige mice. 14 Aortas were harvested at 5 weeks after injection of adenovirus for histological analysis and morphometric assessment of artery graft intima, media, lumen, and vessel area. Expression of IFN-␥, but not LacZ control, induced neointimal formation (Figure 2A , with quantification in Figure 2B ). Unlike the allograft model, no obvious infiltration of leukocytes was detected (Online Figure IV) . Importantly, AIP1-KO donor grafts generated significantly more neointima that contained more SMA ϩ cells than did the WT donor group ( Figure 2C , with quantification in Figure 2D ). To directly assess VSMC proliferation in the neointima, IFN-␥R-KO mouse recipients with WT or AIP1-KO donor grafts were injected with bromodeoxyuridine (BrdU) 3 weeks after administration of adenovirus. Injection was every day for 2 weeks, and grafts were harvested. VSMC proliferation was measured by costaining with antibodies to ␣-SMA and BrdU. Proliferative VSMCs (SMA ϩ BrdU ϩ cells) were detected in the neointima of IFN-␥-treated grafts but not in the LacZ group. AIP1-KO donor grafts showed an increased number of SMA ϩ BrdU ϩ cells in the neointima but not in the media ( Figure 3A , with quantification in Figure 3B ). Aug-mented IFN-␥ signaling in AIP1-KO was also observed by immunostaining with IFN-␥-activated phosphorylated JAK2, phosphorylated STAT1, and phosphorylated STAT3 ( Figure  3C , with quantification in Figure 3D ), as was the IFN-␥responsive gene Mig ( Figures 3E through 3G ). Colocalizations of these IFN-␥-activated signaling molecules with ␣-SMA were observed, which suggests that the IFN-␥ signaling pathway is activated in VSMCs.
AIP1 Deletion Enhances IFN-␥ Responses in Cultured Aorta and Isolated Aortic VSMCs
To determine whether the effect of AIP1 is VSMC autonomous, we examined IFN-␥ responses in isolated aorta and cultured VSMCs from WT and AIP1-KO mice. The organ culture of aortas and cell culture of VSMCs were treated with mouse IFN-␥, and activation of IFN-␥ downstream signaling (phosphorylation of JAK2-STAT1/STAT3) was determined by Western blot with phospho-specific antibodies. AIP1 deletion in both whole aorta and isolated VSMCs caused enhanced IFN-␥-induced activation of JAK2 and STAT1/3 ( Figures 4A and 4B) . Similarly, knockdown of AIP1 in human VSMCs also augmented IFN-␥ responses ( Figure 4C ). IFN-␤-dependent signaling activates TYK2 instead of JAK2, and to test the specificity of AIP1 in VSMCs for IFN-␥, we treated VSMCs with IFN-␤. In contrast to our results with IFN-␥, AIP1 deletion in mouse VSMCs and AIP1 knockdown in human VSMCs had no effect on IFN-␤-dependent signaling, including activation of TYK2, STAT1, and STAT3 (Online Figure V) . Taken together, these results suggest that AIP1 specifically inhibits IFN-␥ responses in VSMCs.
AIP1 Binds JAK2 and Inhibits JAK2 Activity
To define the mechanism by which AIP1 specifically inhibits IFN-␥ signaling, we reasoned that AIP1 associates with the IFN-␥-specific signaling complex (IFN-␥R-JAK2) in VSMCs. Our initial data coimmunoprecipitation assay using coexpression of AIP1 with IFN-␥R, JAK1, or JAK2 in 293T cells indicated that AIP1 was strongly bound to JAK2 but not to JAK1 or IFN-␥R (the IFN-␥R␣ subunit, data not shown).
On the basis of this observation, we further characterized the binding between AIP1 and JAK2. To this end, human VSMCs were treated with human IFN-␥ for various times, and the association of AIP1 with JAK2 was determined by a coimmunoprecipitation assay with anti-AIP1 followed by Western blot with anti-JAK2. An association of AIP1 with JAK2 was not detected in resting VSMCs but was strongly induced by IFN-␥. Kinetics analysis indicated that the association of AIP1 with JAK2 peaked at 15 minutes and was sustained up to 60 minutes ( Figure 5A ). IFN-␥-induced phosphorylation of JAK2 peaked at 5 minutes (see Figure 5C for human VSMCs), which suggests that the AIP1-JAK2 complex is formed at a late phase of IFN-␥ signaling. AIP1 contains a PH domain, a C2 domain, and a GAP domain in the N-terminal half, with a period-like domain, a leucine-zipper motif, and a proline-rich region in the C-terminal half ( Figure 5B ). We first mapped the critical domain of AIP1 for JAK2 binding. Various AIP1 constructs (AIP1-F, AIP1-N, and AIP1-C with N-terminal FLAG tag) were coexpressed with JAK2 in 293T cells, and cells were untreated or treated with IFN-␥. AIP1-JAK2 association was determined by coimmunoprecipitation assay with anti-JAK2 followed by Western blot with anti-FLAG. Association of AIP1-F with JAK2 could be detected in the resting cells and was enhanced by IFN-␥. AIP1-N strongly associated with JAK2 in both resting and IFN-␥-treated cells. In contrast, AIP1-C did not bind to JAK2 under either condition ( Figure  5C ). These data suggest that the N-terminal domain of AIP1 is responsible for JAK2 binding. We also examined the effect of AIP1 coexpression on JAK2 activity. Overexpression of JAK2 induced an autophosphorylation or transphosphorylation of JAK2 that was further enhanced by IFN-␥ treatment, as determined with a phosphorylated JAK2-specific antibody ( Figure 5C ). Interestingly, AIP1-F weakly and AIP1-N strongly inhibited JAK2 activity, which was correlated with the binding ability of AIP1-F and AIP1-N with JAK2 ( Figure  5C ). The specific inhibitory effect of AIP1-N on JAK2 activity was further confirmed by comparison with the control vector ( Figure 5D ). We then defined which structural domain (PH, C2, or GAP) in the N-terminal half was required for JAK2 binding. Various AIP1 N-terminal truncates were generated: AIP1-N (containing all 3 domains), PHC2 (containing the PH and C2 domains), PH (containing only the PH domain), and ⌬PH (with a deletion of the PH domain; Figure  5B ). A deletion of the PH domain (AIP1-⌬PH) or the GAP domain (AIP1-PHC2) reduced the binding of AIP1 to JAK2. A further deletion of the C2 domain (AIP1-PH) ablated the ability to bind JAK2. These results suggest that an intact N-terminal half is required for JAK2 binding. Importantly, the strength of the binding of AIP1 mutants to JAK2 correlated with their inhibitory effects on JAK2 autophosphorylation ( Figure 5E ).
AIP1 Deletion Enhances IFN-␥-JAK2-Dependent VSMC Migration and Proliferation
To correlate the role of AIP1 in IFN-␥ signaling to its effect on in vivo neointima formation, we determined the effects of AIP1 deletion and IFN-␥ signaling inhibitors on VSMC migration and growth, 2 critical steps involved in neointima formation. 36, 37 Human VSMCs were transfected with a control or AIP1 small interfering RNA (siRNA), followed by treatment with human IFN-␥ in the absence or presence of a specific inhibitor to JAK2 (AG490), STAT1 (fludarabine, a purine analog that has been shown to specifically inhibit STAT1 in VSMCs), 38 or STAT3 (Stattic, a nonpeptide small molecule inhibitor of STAT3 activation and dimerization). 39 IFN-␥-induced VSMC migration was measured by monolayer "wound healing" assay. AIP1 knockdown in human VSMCs had no effect on the migration of resting VSMCs but significantly augmented IFN-␥-induced VSMC proliferation (Online Figure VI , A with quantification in Online Figure VI Figure 6D ). These data suggest that AIP1 regulates IFN-␥-induced VSMC migration and proliferation in a JAK2-STAT3-dependent manner. Platelet-derived growth factor (PDGF)-␤ is a potent VSMC mitogen in vivo and in vitro. To exclude a possible role of PDGF-␤ in AIP1regulated VSMC growth, we first measured PDGF-␤ expression in the mouse syngeneic graft model. IFN-␥ did not upregulate gene expression of PDGF-␤ (Online Figure VII) . We then examined the effects of AIP1-KO on PDGF-␤induced VSMC growth and signaling. In contrast to the observations for IFN-␥ responses, AIP1 deletion in mouse VSMC aorta and knockdown in human VSMCs had no effect on PDGF-␤-induced signaling, as determined for phosphorylation of PDGF-R␤, PLC-␥, Akt, and JAK2. (Online Figure  VII) . Similarly, AIP1 deletion or knockdown had no effect on PDGF-␤-induced VSMC proliferation (not shown). These data suggest that AIP1 specifically regulates IFN-␥-dependent functions in VSMCs that are relevant for arteriosclerosis. 
Figure 4. AIP1 deletion augmented the IFN-␥ responses in cultured aorta and isolated aortic VSMCs. A, Aortas dissected from
WT and AIP1-KO mice were cultured overnight in serum-free medium followed by treatment with mouse IFN-␥ (10 ng/mL) for the indicated times. B, WT and AIP1-KO mouse VSMCs were cultured in serum-free medium for 24 hours, followed by treatment with mouse IFN-␥ (mIFN␥; 10 ng/mL) for the indicated times. C, Human VSMCs were transfected with AIP1 or control small interfering RNA (Ctrl siRNA) for 48 hours and cultured in serum-free medium for another 24 hours, followed by treatment with human IFN-␥ (hIFN␥; 10 ng/mL) for the indicated times. In panels A through C, phosphorylation of JAK2, STAT1, and STAT3 and total proteins were determined by Western blot with the respective antibodies. AIP1 and tubulin were also determined. Relative activation of JAK2 (p-JAK2/JAK2), STAT1 (p-STAT1/STAT1), and STAT3 (p-STAT3/STAT3) is shown, with untreated WT or control siRNA as 1.0. For mouse VSMCs and human VSMCs, relative activation of STAT1/3 was normalized by taking the 2-minute time point of IFN-␥ treatment in WT or control siRNA group as 1.0, because basal p-STAT1/3 was undetectable. All experiments were repeated at least 3 times, and data are meanϮSEM from 3 independent blots. *PϽ0.05, WT vs AIP1-KO and Ctrl siRNA vs AIP1 siRNA groups.
Discussion
In the present study, we used 2 mouse GA models, the male-specific minor histocompatibility antigen H-Y-dependent aortic allograft arteriosclerosis model and the IFN-␥ transgene-mediated syngeneic GA model, to investigate the role of AIP1 in GA. We demonstrated that AIP1-KO mice exhibited dramatically enhanced VSMC proliferation and intimal expansion. The donor grafts from AIP1-KO in both models exhibited enhanced IFN-␥ signaling and pathological responses. Mechanistically, we showed that knockout or knockdown of AIP1 in VSMCs significantly augmented IFN-␥-induced signaling and JAK2-STAT1/3-dependent VSMC migration and proliferation, 2 critical steps in neointima formation. Furthermore, we showed that AIP1, via its intact N-terminal domains, associated with JAK2 in response to IFN-␥ and inhibited its activity. We conclude that AIP1 inhibits intimal formation and GA by downregulating IFN-␥-JAK2-STAT1/3dependent migratory and proliferative signaling in VSMCs.
Vascular IFN-␥ Signaling in Mouse GA Models
In the present study, we created 2 new mouse models to verify the role of IFN-␥ in mouse GA. In the first model, a male donor aortic segment was transplanted into a female recipient so that the host induced alloreactive T cell-mediated alloimmune responses against the male-specific minor histocompatibility antigen H-Y expressed on the grafts. 31 Deletion of IFN-␥R in donor grafts blunted leukocyte infiltration and VSMC accumulation in the neointima. This experiment demonstrated a role of IFN-␥ in mice consistent with previous findings from a humanized mouse xenograft transplantation model in which IFN-␥ signaling in graft was critical for GA progression. 10, 11, 13, 14 In the second model, we determined whether IFN-␥ alone was sufficient to induce neointima formation by transplanting a male aorta into a male IFN-␥R-KO recipient animal in which mouse IFN-␥ was then systemically expressed by intravenous injection of replication-deficient adenovirus that encoded the mouse IFN-␥ transgene (Ad-IFN-␥). We observed that expression of IFN-␥, but not LacZ control, induced neointimal formation. Under these conditions, we observed intimal expansion of the graft in the absence of infiltrating leukocytes, once again consistent with previous observations in a human artery-SCID mouse transplantation model in which vascular IFN-␥ signaling alone was sufficient to induce neointima formation in the absence of leukocytes. 13 
AIP1 Inhibits IFN-␥ Signaling in VSMC
The direct effect of IFN-␥ on VSMCs in these new mouse GA models was an intriguing finding. 11, 13, 14 We excluded a possible role of PDGF-␤ (a potent VSMC mitogen) in VSMC growth. However, the molecular mechanism by which IFN-␥ induces VSMC migration and proliferation is not fully understood. Although STAT1-dependent signaling generally has been considered antiproliferative and apoptotic, the observation that IFN-␥-activated PI3K mediates serine phosphorylation and the subsequent full activation of STAT1 may indicate that STAT1 has prosurvival effects. 40 Moreover, recent studies suggest that in some cell types, including VSMCs, IFN-␥ also induces activation of STAT3, [17] [18] [19] [20] which is primarily responsible for cellular growth and survival. [17] [18] [19] [20] The central finding of the present study is that AIP1 is a novel negative regulator of IFN-␥-JAK2-STAT1/3 signaling in VSMCs. It has been shown previously that JAK-STAT signaling can be negatively regulated through 3 main mechanisms: the dephosphorylation of JAKs or STATs by various protein tyrosine phosphatases, such as the Src homology region 2 domain-containing phosphatases 1 and 2; the inactivation of JAKs by the suppressor of cytokine signaling (SOCS) family of proteins; and the inhibition of the transcriptional activity of STATs by protein inhibitor of STAT (PIAS) proteins. 41, 42 Here, we demonstrate that AIP1 directly binds to JAK2 and inhibits JAK2 kinase activity. Therefore, AIP1 acts in a similar manner as the SOCS family (SOCS1). We do not yet know whether AIP1 and SOCS1 function synergistically in the inhibition of IFN-␥ signaling.
An important finding in the present study is that AIP1 associates with JAK2 in response to IFN-␥ and inhibits JAK2 autokinase activity, thereby preventing JAK2-dependent STAT1/3 tyrosine phosphorylation. Consistent with a previous report, 14 we observed that IFN-␥ also activated PI3K-Akt-mTOR signaling in VSMCs. AIP1-knockdown human VSMCs exhibited enhanced IFN-␥-induced phosphorylation of Akt-mTOR (Online Figure VIII) . In contrast, AIP1 deletion had no effect on either PDGF-BB-induced JAK2 or Akt activation (Online Figure VII) . It is plausible that AIP1 inhibits JAK2 and PI3K-Akt in a receptor-complex-dependent manner. In support of this model, our previous studies have demonstrated that AIP1 associates with the vascular endothelial growth factor-activated VEGFR2-PI3K complex, in which AIP1, via its C2 domain and proline-rich motif, binds to VEGFR2 and PI3K, respectively. 27, 43 A JAK2 inhibitor had a stronger inhibitory effect than an Akt inhibitor on AIP1 deletion-augmented VSMC migration in response to IFN-␥ (Online Figure VIII) . These data suggest that IFN-␥-induced JAK2-STAT1/3 is a primary target of AIP1 in VSMCs.
AIP1 Regulation in GA
We have demonstrated previously in mouse models that AIP1 in vascular ECs functions as an endogenous inhibitor of inflammatory responses. 27 It has been proposed that vascular ECs may selectively recruit or activate IFN-␥-secreting T cells to graft vessels, and IFN-␥ in turn contributes to the pathogenesis of GA by modulating functions of VSMCs. Therefore, the functional effect of IFN-␥ on ECs may be an early event that occurs before and is causally linked to smooth muscle cell accumulation. 1, 12 We cannot exclude a role of EC-expressed AIP1 in the allograft model, in which AIP1 in ECs may control infiltration of T cells, which in turn regulate VSMC proliferation. 12 However, our studies using in vitro VSMC culture and the IFN-␥-induced syngeneic graft model support a critical role of VSMC-expressed AIP1 in regulation of GA. Further investigation will be warranted to use EC-and VSMC-specific AIP1 KO mice to determine the relative importance of these effects. Nevertheless, the present results in both ECs and VSMCs suggest that AIP1 is an important regulator in maintaining normal function of the vasculature. A recent human genome-wide association study has identified AIP1 (DAB2IP) as a susceptibility gene for abdominal aortic aneurysm, peripheral vascular disease, early onset of myocardial infarction, and pulmonary embolism. 30 AIP1 expression is primarily regulated by epigenetic modification in its promoter region in tumors. 29, 44 A future analysis of the regulation of AIP1 expression during GA progression should help to define whether AIP1 is a potential therapeutic target for the prevention of GA and other vascular diseases.
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